We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Arachidonic Acid Stimulates Cancer Growth

By Biotechdaily staff writers
Posted on 16 Feb 2006
Researchers have found that arachidonic acid, an omega-6 fatty acid, stimulated the growth of tumor cells by activating the metabolic pathway leading to prostaglandin synthesis and translocation to the nucleus of nuclear factor-kappaB (NF-kappaB).

Investigators at the San Francisco Veterans Administration Medical Center (CA, USA) added arachidonic acid to human prostate tumor cells growing in tissue culture. More...
They found that this prompted the cells to grow at a rate nearly double that of control cells that did not receive arachidonic acid.

Analysis using gene chip technology showed that arachidonic acid induced 11 genes that were regulated by NF-kappaB. Within five minutes of addition of arachidonic acid prostaglandin E2 (PGE2) synthesis was increased, and analysis of upstream signal transduction showed that phosphatidylinositol 3-kinase (PI3K) was significantly activated. These events were followed by activation of Akt at 30 minutes, when a significant three-fold increase in translocation of NF-kappaB to the nucleus was seen. Interruption of the pathway by treatment with either a COX-2 inhibitor or with a PI3K inhibitor reversed the stimulatory effect of arachidonic acid. These findings were published in the February 1, 2006, issue of Cancer Research.

Senior author Dr. Mille Hughes-Fulford, director of the Laboratory of Cell Growth at the San Francisco Veterans Administration Medical Center, said, "Investigating the reasons for this rapid growth, we discovered that the omega-6 was turning on a dozen inflammatory genes that are known to be important in cancer. We then asked what was turning on those genes, and found that omega-6 fatty acids actually turn on a signal pathway called PI3-kinase that is known to be a key player in cancer. I am not a physician, and do not tell people how to eat, but in my own home I use only canola oil and olive oil. We do not eat deep-fried foods.”



Related Links:
San Francisco Veterans Administration Medical Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Automated Clinical Chemistry Analyzer
Envoy 500+
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Takotsubo syndrome is a condition characterized by acute transient left ventricular systolic dysfunction and can be difficult to distinguish from acute myocardial infarction at presentation (Image Credit: Adobe Stock)

Biomarker Score Helps Differentiate Takotsubo Syndrome from Myocardial Infarction

Takotsubo syndrome, often called broken-heart syndrome, mimics myocardial infarction and can be difficult to triage in emergency settings. It accounts for about 2% of suspected heart attacks and up to... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.